GSK1605786

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Colitis, UlcerativeCrohn's Disease

Phase 1

Japanese Phase I of GSK1605786

CompletedNCT01611805

GlaxoSmithKlineCrohn's Disease

Start: 2010-07-22End: 2010-10-06Updated: 2017-06-14

Phase 2

A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis

WithdrawnNCT01658605

GlaxoSmithKlineColitis, Ulcerative

Start: 2013-02-28End: 2014-12-31Updated: 2013-06-24